Combination medicine of cefetaprost and Rho kinase inhibitor

摘要

It is an object of the present invention to find out a combination of drugs for preventing or treating glaucoma or ocular hypertension, which is useful as a prophylactic or therapeutic agent for glaucoma or ocular hypertension. By combining cefetaprost with a Rho kinase inhibitor, the lowering of intraocular pressure is enhanced compared to when each drug is used alone. As a dosage form, it may be administered in combination or may be administered as a combination agent.